Hanall Biopharma’s global expansion chosen as one of ’10 Most Outstanding Scientific Technology News’

Published: 2018-01-08 09:40:30

Updated: 2018-01-08 09:40:30

Hanall Biopharma’ large biotechnology export was selected as one of the ’10 Most Outstanding Scientific Technology News of The Year’ by the Korean Federation of Science and Technology Societies(KOFST).

Last December, Hanall Biopharma has succeeded in exporting its technology license of HL161, a new antibody for the treatment of autoimmune disease in the process of Phase I clinical trial, to Sw...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.